Cargando…

Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community

BACKGROUND: Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death. Few persons who initiate MOUD are retained on treatment, thus it is critical to identify factor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biondi, Breanne E., Vander Wyk, Brent, Schlossberg, Esther F., Shaw, Albert, Springer, Sandra A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899775/ https://www.ncbi.nlm.nih.gov/pubmed/35255967 http://dx.doi.org/10.1186/s13722-022-00299-1

Ejemplares similares

Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder
por: Biondi, Breanne E., et al.
Publicado: (2021)

Evaluation of the Impact of HIV Serostatus on the Hepatitis C Virus Care Cascade and Injection Drug Use Among Persons Initiating Medication Treatment for Opioid Use Disorder
por: Lier, Audun J, et al.
Publicado: (2022)

A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease Outcomes
por: McNamara, Katelyn F, et al.
Publicado: (2021)

Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review
por: Chan, Brian, et al.
Publicado: (2021)

Educating the community about the opioid epidemic and medications for opioid use disorder
por: Williams, Jill M., et al.
Publicado: (2022)

Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners
por: Springer, Sandra A., et al.
Publicado: (2012)

Reduced Sexual Risk Behaviors Among Persons With HIV After Release From the Criminal Justice System
por: Biondi, Breanne E, et al.
Publicado: (2019)

The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review
por: Russell, Cayley, et al.
Publicado: (2023)

Potential Effects of Digital Inequality on Treatment Seeking for Opioid Use Disorder
por: Garett, Renee, et al.
Publicado: (2021)

Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence
por: Schultheis, Alysse, et al.
Publicado: (2021)

Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder
por: Clingan, Sarah E., et al.
Publicado: (2023)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder
por: Joudrey, Paul J., et al.
Publicado: (2022)

Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non‐Clinicians
por: Di Paola, Angela, et al.
Publicado: (2023)

Trait-level temporal lobe hypoactivation to social exclusion in unaffected siblings of children and adolescents with autism spectrum disorders
por: Bolling, Danielle Z., et al.
Publicado: (2015)

Multifaceted Quality Improvement Initiative Improves Retention in Treatment for Youth with Opioid Use Disorder
por: Cottrill, Casey B., et al.
Publicado: (2019)

Retention in the Austrian opioid agonist treatment system: a national prospective cohort study
por: Busch, Martin, et al.
Publicado: (2021)

Experiences of Parents with Opioid Use Disorder during Their Attempts to Seek Treatment: A Qualitative Analysis
por: Bakos-Block, Christine, et al.
Publicado: (2022)

Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic
por: Jones, Christopher M., et al.
Publicado: (2022)

Beyond Antibiotics: A Practical Guide for the Infectious Disease Physician to Treat Opioid Use Disorder in the Setting of Associated Infectious Diseases
por: Seval, Nikhil, et al.
Publicado: (2019)

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV
por: Parchinski, Kaley, et al.
Publicado: (2023)

The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study
por: Gisev, Natasa, et al.
Publicado: (2019)

Determinants and rates of retention in HIV care among adolescents receiving antiretroviral therapy in Windhoek, Namibia: a baseline cohort analysis
por: Munyayi, Farai K., et al.
Publicado: (2023)

Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting
por: Sweeney, Mary M., et al.
Publicado: (2022)

Opioid use among patients with pain syndromes commonly seeking surgical consultation: A retrospective cohort
por: Kin, Cindy, et al.
Publicado: (2021)

Seeking to understand lived experiences of personal recovery in personality disorder in community and forensic settings – a qualitative methods investigation
por: Shepherd, Andrew, et al.
Publicado: (2017)

Retention in Georgia opioid substitution therapy program and associated factors
por: Ruadze, Ekaterine, et al.
Publicado: (2016)

Retention of patients in opioid substitution treatment: A systematic review
por: O’Connor, Aisling Máire, et al.
Publicado: (2020)

Medication Assisted Treatment for Opioid Use Disorder
por: McKay, Catherine Devaney
Publicado: (2017)

Rapid Access to Medications for Opioid Use Disorder
por: Kleinman, Robert A., et al.
Publicado: (2021)

Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonism
por: Giuliano, Chiara, et al.
Publicado: (2013)

An opioid-gated thalamoaccumbal circuit for the suppression of reward seeking in mice
por: Vollmer, Kelsey M., et al.
Publicado: (2022)

Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic
por: Frost, Madeline C., et al.
Publicado: (2022)

Inhibition of Opioid Transmission at the μ-Opioid Receptor Prevents Both Food Seeking and Binge-Like Eating
por: Giuliano, Chiara, et al.
Publicado: (2012)

Type of opioid dependence among patients seeking opioid substitution treatment: are there differences in background and severity of problems?
por: Monwell, Bodil, et al.
Publicado: (2016)

Addressing the Intersection of Infectious Disease Epidemics and Opioid and Substance Use Epidemics
por: Springer, Sandra A., et al.
Publicado: (2020)

Non-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review
por: Tetrault, Jeanette M., et al.
Publicado: (2015)

Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study
por: Poulsen, Melissa N., et al.
Publicado: (2022)

Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021
por: Jones, Christopher M., et al.
Publicado: (2023)

Clinical features of olfactory disorders in patients seeking medical consultation
por: Chen, Guowei, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ocv89ku6bqt8ml3sbd1el8ch27